{"id":"as-mdi","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"AS MDI represents a delivery system rather than a novel molecular entity. The specific mechanism depends on the active ingredient contained within the formulation. As an MDI (metered-dose inhaler), it is designed to provide precise, reproducible doses of medication via inhalation, targeting pulmonary and/or systemic pathways depending on the drug's properties and intended indication.","oneSentence":"AS MDI is a metered-dose inhaler formulation that delivers an active pharmaceutical agent directly to the respiratory tract for local and/or systemic therapeutic effect.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:41.075Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04886999","phase":"PHASE3","title":"Study in Adult Patients With Moderate to Severe Asthma","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2022-02-24","conditions":"Asthma","enrollment":78},{"nctId":"NCT07073950","phase":"PHASE4","title":"A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-24","conditions":"Chronic Obstructive Pulmonary Disease, Hyperinflation","enrollment":56},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT06471257","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-06-17","conditions":"Asthma","enrollment":790},{"nctId":"NCT07426458","phase":"PHASE4","title":"Ventilation and Perfusion in Asthmatics","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-04","conditions":"Asthma","enrollment":40},{"nctId":"NCT07463911","phase":"","title":"Treatment Response In ECT Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nurdan Sağbaş","startDate":"2025-05-20","conditions":"Major Depression, Bipolar Affective Disorder, Bipolar Depression Depressed Phase","enrollment":65},{"nctId":"NCT07433569","phase":"PHASE1","title":"A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-03-05","conditions":"Asthma","enrollment":12},{"nctId":"NCT07381166","phase":"NA","title":"The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals","status":"RECRUITING","sponsor":"Çanakkale Onsekiz Mart University","startDate":"2026-01-21","conditions":"Elderly (People Aged 65 or More)","enrollment":64},{"nctId":"NCT06307665","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-05-20","conditions":"Asthma","enrollment":440},{"nctId":"NCT06067828","phase":"PHASE3","title":"A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-10-24","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":171},{"nctId":"NCT06563102","phase":"PHASE4","title":"Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-09-11","conditions":"Mild Asthma","enrollment":101},{"nctId":"NCT06449677","phase":"PHASE3","title":"Bionic Pancreas in CFRD","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2024-09-24","conditions":"Cystic Fibrosis-related Diabetes","enrollment":150},{"nctId":"NCT07406048","phase":"","title":"Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients","status":"NOT_YET_RECRUITING","sponsor":"Chiesi Farmaceutica Ltda.","startDate":"2026-01-30","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":396},{"nctId":"NCT07402928","phase":"","title":"Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease","status":"RECRUITING","sponsor":"Danish Research Centre for Magnetic Resonance","startDate":"2025-06-02","conditions":"Healthy, Parkinson, Medication Administration","enrollment":140},{"nctId":"NCT05922761","phase":"PHASE2","title":"BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-05-31","conditions":"Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases","enrollment":45},{"nctId":"NCT06825871","phase":"NA","title":"Automated Inhaler Monitoring for Asthma Medication Usage","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-12-15","conditions":"Asthma","enrollment":26},{"nctId":"NCT06429475","phase":"PHASE3","title":"Anti-Inflammatory Reliever South Africa","status":"RECRUITING","sponsor":"University of KwaZulu","startDate":"2024-06-06","conditions":"Asthma","enrollment":1038},{"nctId":"NCT06433908","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-06-04","conditions":"Asthma, Healthy Participants","enrollment":60},{"nctId":"NCT07304778","phase":"NA","title":"Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2025-07-11","conditions":"Diabetes (Insulin-requiring, Type 1 or Type 2)","enrollment":34},{"nctId":"NCT07315555","phase":"NA","title":"Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Community Acquired Pneumonia","enrollment":90},{"nctId":"NCT05413005","phase":"EARLY_PHASE1","title":"Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abu Dhabi Stem Cells Center","startDate":"2022-09-05","conditions":"Type 1 Diabetes","enrollment":10},{"nctId":"NCT06422689","phase":"PHASE4","title":"Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-05-10","conditions":"Asthma","enrollment":1507},{"nctId":"NCT06368427","phase":"","title":"Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-04-30","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":10},{"nctId":"NCT06110403","phase":"PHASE1, PHASE2","title":"Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2023-09-29","conditions":"Copd","enrollment":35},{"nctId":"NCT06645834","phase":"NA","title":"Smart MDI Study (CIP343)","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2024-12-06","conditions":"Diabetes Mellitus, Type 1","enrollment":179},{"nctId":"NCT07241702","phase":"","title":"EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Attikon Hospital","startDate":"2019-09-01","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT07232264","phase":"NA","title":"Respiratory and Peripheral Muscle Strength as Predictors of Inhaler Treatment Response in Asthma: A Comparison of DPI and MDI Devices","status":"COMPLETED","sponsor":"Bugra Kerget","startDate":"2025-03-01","conditions":"Asthma (Diagnosis)","enrollment":80},{"nctId":"NCT06433921","phase":"PHASE1","title":"A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-08-14","conditions":"Asthma, Mild Asthma","enrollment":84},{"nctId":"NCT04443153","phase":"NA","title":"Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-09-04","conditions":"Diabetes Mellitus, Type 1","enrollment":88},{"nctId":"NCT06411548","phase":"NA","title":"InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2025-03-27","conditions":"Type 1 Diabetes Mellitus","enrollment":7},{"nctId":"NCT07200739","phase":"","title":"Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Zealand University Hospital","startDate":"2025-10-01","conditions":"Dementia (Diagnosis), Alzheimer Dementia (AD), Vascular Dementia (VaD)","enrollment":340},{"nctId":"NCT06644924","phase":"PHASE2","title":"A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-02-10","conditions":"Asthma","enrollment":118},{"nctId":"NCT06792175","phase":"","title":"Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models","status":"ENROLLING_BY_INVITATION","sponsor":"Psyrin Inc.","startDate":"2025-02-04","conditions":"Autism Spectrum Disorder, Depression - Major Depressive Disorder, Anxiety, Generalized","enrollment":500},{"nctId":"NCT05477108","phase":"PHASE1","title":"Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-07-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":108},{"nctId":"NCT06075095","phase":"PHASE3","title":"A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPD","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-01-11","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":297},{"nctId":"NCT06245551","phase":"PHASE3","title":"A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-12-22","conditions":"Asthma, Exercise-Induced","enrollment":64},{"nctId":"NCT06514157","phase":"PHASE1","title":"Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-08-19","conditions":"Healthy Volunteer","enrollment":14},{"nctId":"NCT05569421","phase":"PHASE1","title":"A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-10-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":108},{"nctId":"NCT02748018","phase":"NA","title":"Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2017-05-25","conditions":"Type 1 Diabetes","enrollment":959},{"nctId":"NCT06340581","phase":"PHASE1","title":"A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2024-10-17","conditions":"Healthy","enrollment":""},{"nctId":"NCT06297668","phase":"PHASE1","title":"A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-04-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":42},{"nctId":"NCT05505734","phase":"PHASE3","title":"A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2022-09-02","conditions":"Asthma","enrollment":2516},{"nctId":"NCT04480242","phase":"","title":"Asthma Research in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2017-07-26","conditions":"Persistent Asthma, Asthma in Children, Asthma Exacerbation","enrollment":525},{"nctId":"NCT05819541","phase":"PHASE2","title":"Treating Exacerbations of Asthma With Oral Montelukast in Children","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-10-20","conditions":"Status Asthmaticus","enrollment":90},{"nctId":"NCT07030881","phase":"NA","title":"Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Ningbo University","startDate":"2025-06-20","conditions":"Asthma, COPD","enrollment":380},{"nctId":"NCT06723756","phase":"PHASE1","title":"A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-01-23","conditions":"Healthy Participants","enrollment":105},{"nctId":"NCT05035862","phase":"PHASE1","title":"Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma","status":"TERMINATED","sponsor":"Emory University","startDate":"2022-03-16","conditions":"Asthma","enrollment":1},{"nctId":"NCT05967260","phase":"NA","title":"DailyDose Smart Snack Study for T1D on MDI","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2023-09-01","conditions":"Type 1 Diabetes Mellitus With Hypoglycemia","enrollment":21},{"nctId":"NCT04935307","phase":"NA","title":"Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy Controls","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2021-11-02","conditions":"Functional Disorder, Bodily Distress Syndrome, Multiple Chemical Sensitivity","enrollment":40},{"nctId":"NCT01073566","phase":"PHASE2","title":"Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections","status":"COMPLETED","sponsor":"Calibra Medical, Inc.","startDate":"2010-01","conditions":"Diabetes Mellitus","enrollment":38},{"nctId":"NCT03924635","phase":"PHASE4","title":"An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-08-01","conditions":"Airway Inflammation, Asthma","enrollment":42},{"nctId":"NCT06611228","phase":"NA","title":"Optimizing Prevention of Hospital-Acquired Disability Through Multidomain Interventions","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2024-12-01","conditions":"Frailty Syndrome, Aging","enrollment":288},{"nctId":"NCT04276233","phase":"PHASE4","title":"Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-06-29","conditions":"Asthma","enrollment":100},{"nctId":"NCT06656806","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety","status":"NOT_YET_RECRUITING","sponsor":"Trinity Hypertension & Metabolic Research Institute","startDate":"2024-12-01","conditions":"Generalized Anxiety Disorder","enrollment":40},{"nctId":"NCT03562195","phase":"PHASE3","title":"A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-08-29","conditions":"Asthma","enrollment":300},{"nctId":"NCT01416220","phase":"PHASE4","title":"Lithium Versus Paroxetine in Major Depression","status":"WITHDRAWN","sponsor":"Nova Scotia Health Authority","startDate":"2011-09","conditions":"Major Depressive Disorder","enrollment":""},{"nctId":"NCT00070707","phase":"PHASE4","title":"Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-03","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":188},{"nctId":"NCT06560749","phase":"NA","title":"Physical Exercise for Cognitive Rehabilitation of Patients With Bipolar Affective Disorder","status":"RECRUITING","sponsor":"Beny Lafer","startDate":"2024-08-20","conditions":"Bipolar Disorder","enrollment":72},{"nctId":"NCT05904743","phase":"PHASE4","title":"INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2023-07-07","conditions":"Diabetes Mellitus, Type 1","enrollment":141},{"nctId":"NCT02558491","phase":"NA","title":"Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM","status":"COMPLETED","sponsor":"Daniel Chernavvsky, MD","startDate":"2015-09","conditions":"Type 1 Diabetes Mellitus","enrollment":33},{"nctId":"NCT06139991","phase":"PHASE1","title":"Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-11-16","conditions":"Heathy Participants","enrollment":66},{"nctId":"NCT01471340","phase":"PHASE4","title":"A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-01-09","conditions":"Asthma","enrollment":11744},{"nctId":"NCT01258803","phase":"PHASE2","title":"A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-12","conditions":"Asthma","enrollment":92},{"nctId":"NCT00604500","phase":"PHASE3","title":"A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-03-01","conditions":"Asthma, COPD","enrollment":272},{"nctId":"NCT02741271","phase":"PHASE3","title":"Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2016-05-11","conditions":"Asthma","enrollment":181},{"nctId":"NCT06071325","phase":"","title":"Green Digital Diabetes Waste Project","status":"COMPLETED","sponsor":"Florida State University","startDate":"2023-09-19","conditions":"Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":49},{"nctId":"NCT06042062","phase":"NA","title":"Clinical Evaluation of Infection Control to Knee Periprosthetic Joint Infection (PJI) -United Cellbrick Knee Spacer","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-08-01","conditions":"Knee; Infection, Joint","enrollment":10},{"nctId":"NCT05610722","phase":"NA","title":"Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1","status":"TERMINATED","sponsor":"Rabin Medical Center","startDate":"2022-11-06","conditions":"Type 1 Diabetes","enrollment":1},{"nctId":"NCT04653961","phase":"NA","title":"Evaluation of a Decision Support System for People With Diabetes Who Use Multiple Daily Insulin Injections- Feasibility and Proof of Concept Studies","status":"RECRUITING","sponsor":"Rabin Medical Center","startDate":"2020-06-01","conditions":"Type1diabetes","enrollment":48},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT06236256","phase":"NA","title":"Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2024-01-09","conditions":"Diabetes Mellitus, Type 1","enrollment":40},{"nctId":"NCT05970263","phase":"PHASE4","title":"IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2024-01-19","conditions":"COPD","enrollment":""},{"nctId":"NCT06197048","phase":"NA","title":"Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder","status":"RECRUITING","sponsor":"Vestre Viken Hospital Trust","startDate":"2023-09-25","conditions":"Cardiovascular Diseases, Schizophrenia, Psychosis","enrollment":40},{"nctId":"NCT06185283","phase":"NA","title":"Milled in Versus Round Bar for Mini-implant Retained Mandibular Overdentures","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2015-05","conditions":"Bone Loss","enrollment":18},{"nctId":"NCT03676465","phase":"NA","title":"CloudConnect: Predictive And Retrospective Clinical Decision Support For Chronic Disease Management","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2019-01-18","conditions":"Type 1 Diabetes Mellitus","enrollment":132},{"nctId":"NCT03453112","phase":"PHASE3","title":"Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2017-10-09","conditions":"Asthma","enrollment":494},{"nctId":"NCT05951283","phase":"NA","title":"Quantifying Artificial Pancreas-related Changes in Diabetic Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Manchester University NHS Foundation Trust","startDate":"2023-12-01","conditions":"Diabetes Complications, Diabetes Mellitus, Type 1, Diabetic Neuropathies","enrollment":102},{"nctId":"NCT00576069","phase":"","title":"Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma","status":"RECRUITING","sponsor":"Gelb, Arthur F., M.D.","startDate":"2007-10-25","conditions":"Asthma","enrollment":60},{"nctId":"NCT05084222","phase":"PHASE4","title":"Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2021-11-11","conditions":"Asthma","enrollment":180},{"nctId":"NCT05969106","phase":"","title":"Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2020-01-01","conditions":"Type 1 Diabetes","enrollment":84},{"nctId":"NCT04892758","phase":"","title":"Replication of the P04334 Asthma Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-10-29","conditions":"Asthma","enrollment":10288},{"nctId":"NCT00357890","phase":"NA","title":"Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2005-12","conditions":"Diabetes Mellitus, Insulin-Dependent","enrollment":12},{"nctId":"NCT04796779","phase":"NA","title":"The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes","status":"COMPLETED","sponsor":"Marc Breton","startDate":"2021-04-21","conditions":"Type 1 Diabetes","enrollment":102},{"nctId":"NCT03847896","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2019-03-20","conditions":"Asthma","enrollment":1001},{"nctId":"NCT03620747","phase":"PHASE3","title":"Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-08-30","conditions":"Asthma","enrollment":393},{"nctId":"NCT01721291","phase":"PHASE4","title":"Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2012-10-01","conditions":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, HEALTHY SUBJECTS","enrollment":65},{"nctId":"NCT05574023","phase":"NA","title":"Effect of CGM With Predictive Alarm on Hypoglycemia in Young Patients With T1D.","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-05-10","conditions":"Type 1 Diabetes","enrollment":20},{"nctId":"NCT03769090","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2018-12-13","conditions":"Asthma","enrollment":3132},{"nctId":"NCT04091360","phase":"PHASE2","title":"A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2019-04-29","conditions":"COPD","enrollment":40},{"nctId":"NCT05429359","phase":"NA","title":"cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances","status":"UNKNOWN","sponsor":"University Hospital, Antwerp","startDate":"2022-10-01","conditions":"Diabetes Mellitus, Type 1","enrollment":50},{"nctId":"NCT04871958","phase":"NA","title":"Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward","status":"TERMINATED","sponsor":"Federico II University","startDate":"2021-03-19","conditions":"Diabetes Mellitus, Covid19","enrollment":66},{"nctId":"NCT03557892","phase":"NA","title":"Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2018-04-01","conditions":"Diabetes Mellitus, Type 1","enrollment":28},{"nctId":"NCT03615248","phase":"EARLY_PHASE1","title":"Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma","status":"COMPLETED","sponsor":"Memorial University of Newfoundland","startDate":"2021-01-01","conditions":"Asthma, Asthma in Children","enrollment":30},{"nctId":"NCT04402658","phase":"NA","title":"Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?","status":"WITHDRAWN","sponsor":"Norwegian School of Sport Sciences","startDate":"2022-08-01","conditions":"Sports Drug Abuse","enrollment":""},{"nctId":"NCT01615874","phase":"PHASE2","title":"Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT01056159","phase":"PHASE1","title":"A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-01","conditions":"Asthma","enrollment":47},{"nctId":"NCT01899144","phase":"PHASE2","title":"Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-07","conditions":"Asthma","enrollment":61},{"nctId":"NCT02139644","phase":"PHASE3","title":"Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-06","conditions":"Asthma","enrollment":787},{"nctId":"NCT00577655","phase":"PHASE3","title":"Albuterol HFA MDI in Pediatric Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2007-08","conditions":"Asthma","enrollment":103},{"nctId":"NCT04189510","phase":"NA","title":"Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-04-01","conditions":"Type 1 Diabetes, Insulin-requiring Type 2 Diabetes Mellitus, End Stage Renal Disease (ESRD)","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5049,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AS MDI","genericName":"AS MDI","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}